Advisory Committee on Organ Transplantation Request for Nominations for Voting Members, 14058-14059 [2014-05375]

Download as PDF 14058 Federal Register / Vol. 79, No. 48 / Wednesday, March 12, 2014 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—Continued Number of respondents Form name Number of responses per respondent Average burden per response (in hours) Total responses Total burden hours Later Implementation Site Visit Interview Guide ................. List of Site HIV Outpatient Ambulatory Medical Care Activities/Services ................................................................. 90 1 1 1 90 30 1 1 30/60 15 Total .............................................................................. ........................ ........................ ........................ ........................ 285 Dated: March 6, 2014. Jackie Painter, Deputy Director, Division of Policy and Information Coordination. [FR Doc. 2014–05376 Filed 3–11–14; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Committee on Organ Transplantation Request for Nominations for Voting Members Health Resources and Services Administration, HHS. ACTION: Notice. AGENCY: The Health Resources and Services Administration (HRSA) is requesting nominations to fill vacancies on the Advisory Committee on Organ Transplantation (ACOT). The ACOT was established by the Amended Final Rule of the Organ Procurement and Transplantation Network (OPTN) (42 CFR Part 121) and, in accordance with Public Law 92–463, was chartered on September 1, 2000. DATES: The agency will receive nominations on a continuous basis. ADDRESSES: All nominations should be submitted to the Executive Secretary, ACOT, Healthcare Systems Bureau, HRSA, Parklawn Building, Room 12C– 06, 5600 Fishers Lane, Rockville, Maryland 20857. Federal Express, Airborne, UPS etc. mail delivery should be addressed to Executive Secretary, Advisory Committee on Organ Transplantation, Healthcare Systems Bureau, HRSA, at the above address, or via email to: PStroup@hrsa.gov and PTongele@hrsa.gov. FOR FURTHER INFORMATION CONTACT: Patricia A. Stroup, M.B.A., M.P.A., Executive Secretary, ACOT, at (301) 443–1127 or email pstroup@hrsa.gov. SUPPLEMENTARY INFORMATION: As provided by 42 CFR 121.12, the Secretary established the ACOT. The ACOT is governed by the Federal tkelley on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:51 Mar 11, 2014 Jkt 232001 Advisory Committee Act (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. The ACOT advises the Secretary on all aspects of organ procurement, allocation, and transplantation, and on other such matters that the Secretary determines. One of its principal functions is to advise the Secretary on federal efforts to maximize the number of deceased donor organs made available for transplantation and to support the safety of living organ donation. The ACOT consists of up to 25 members who are Special Government Employees, and 5 ex-officio, non-voting members. Members and the Chair shall be appointed by the Secretary from individuals knowledgeable in such fields as deceased and living organ donation, health care public policy, transplantation medicine and surgery, critical care medicine and other medical specialties involved in the identification and referral of donors, non-physician transplant professions, nursing, epidemiology, immunology, law and bioethics, behavioral sciences, economics and statistics, as well as representatives of transplant candidates, transplant recipients, living organ donors, and family members of deceased and living organ donors. Members shall not serve while they are also serving on the OPTN Board of Directors. To the extent practicable, Committee members should represent minority, gender, and geographic diversity of transplant candidates, transplant recipients, organ donors, and family members served by the OPTN. The ex-officio, non-voting members shall include the Directors of the National Institutes of Health, the Centers for Disease Control and Prevention, and the Agency for Healthcare Research and Quality; the Administrator of the Centers for Medicare and Medicaid Services; and the Commissioner of the Food and Drug Administration—or their designees. Specifically, HRSA is requesting nominations for voting members of the ACOT representing: Health care public PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 policy; transplantation medicine and surgery, including pediatric and heart/ lung transplantation; critical care medicine; nursing; epidemiology and applied statistics; immunology; law and bioethics; behavioral sciences; economics and econometrics; organ procurement organizations; transplant candidates/recipients; transplant/donor family members; and living donors. Nominees will be invited to serve up to a 4-year term beginning the date of appointment. The Department of Health and Human Services (HHS) will consider nominations of all qualified individuals with a view to ensuring that the ACOT includes the areas of subject matter expertise noted above. Individuals may nominate themselves or other individuals, and professional associations and organizations may nominate one or more qualified persons for membership on the ACOT. Nominations shall state that the nominee is willing to serve as a member of the ACOT and appears to have no conflict of interest that would preclude the ACOT membership. Potential candidates will be asked to provide detailed information concerning financial interests, consultancies, research grants, and/or contracts that might be affected by recommendations of the ACOT to permit evaluation of possible sources of conflicts of interest. A nomination package should include the following information for each nominee: (1) A letter of nomination stating the name, affiliation, and contact information for the nominee, the basis for the nomination (i.e., what specific attributes, perspectives, and/or skills does the individual possess that would benefit the workings of ACOT), and the nominee’s field(s) of expertise; (2) a biographical sketch of the nominee and a copy of his/her curriculum vitae; and (3) the name, address, daytime telephone number, and email address at which the nominator can be contacted. HHS strives to ensure that the membership of HHS Federal advisory committees is fairly balanced in terms of points of view represented and the committee’s function. Every effort is E:\FR\FM\12MRN1.SGM 12MRN1 Federal Register / Vol. 79, No. 48 / Wednesday, March 12, 2014 / Notices made to ensure that the views of women, all ethnic and racial groups, and people with disabilities are represented on HHS Federal advisory committees. The Department also encourages geographic diversity in the composition of the committee. The Department encourages nominations of qualified candidates from all groups and locations. Appointment to the ACOT shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, disability, and cultural, religious, or socioeconomic status. Dated: March 6, 2014. Jackie Pianter, Deputy Director, Division of Policy and Information Coordination. [FR Doc. 2014–05375 Filed 3–11–14; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute; Notice of Closed Meeting tkelley on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NEI—Clinical Trial Cooperative Agreement Applications and Other Clinically-Based Applications. Date: April 10, 2014. Time: 8:30 a.m. To 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, Rockville, MD 20814. Contact Person: Anne E. Schaffner, Ph.D., Chief, Scientific Review Branch, Division of Extramural Research, National Eye Institute, 5635 Fishers Lane, Suite 1300, MSC 9300, Bethesda, MD 20892–9300, (301) 451–2020, aes@nei.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS). VerDate Mar<15>2010 17:51 Mar 11, 2014 Jkt 232001 Dated: March 6, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–05346 Filed 3–11–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of General Medical Sciences Special Emphasis Panel, March 26, 2014, 1:00 p.m. to March 26, 2014, 4:00 p.m., National Institutes of Health, Natcher Building, 45 Center Drive, Room 3An.18A, Bethesda, MD 20892 which was published in the Federal Register on March 5, 2014, 79 FR 12516. The meeting will start on March 26, 2014 at 11:30 a.m. and end March 26, 2014 at 4:30 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: March 6, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–05344 Filed 3–11–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Clinical Trials in Organ Transplantation (U01). Date: April 3–4, 2014. PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 14059 Time: April 3, 2014, 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, The Madison Room, 1750 Rockville Pike, Rockville, MD 20852. Time: April 4, 2014, 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, The Madison Room, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Andrea L Wurster, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 3259, 6700B Rockledge Drive, MSC–7616, Bethesda, MD 20892–761‘, 301–451–2660, wurstera@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS). Dated: March 6, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–05267 Filed 3–11–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Health and Aging. Date: April 8, 2014. Time: 2:00 p.m. to 3:45 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, Suite 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892. Contact Person: Rebecca J. Ferrell, Ph.D., Scientific Review Officer, National Institute on Aging, Gateway Building Rm. 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–402–7703, ferrellrj@mail.nih.gov. E:\FR\FM\12MRN1.SGM 12MRN1

Agencies

[Federal Register Volume 79, Number 48 (Wednesday, March 12, 2014)]
[Notices]
[Pages 14058-14059]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05375]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Organ Transplantation Request for 
Nominations for Voting Members

AGENCY: Health Resources and Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Health Resources and Services Administration (HRSA) is 
requesting nominations to fill vacancies on the Advisory Committee on 
Organ Transplantation (ACOT). The ACOT was established by the Amended 
Final Rule of the Organ Procurement and Transplantation Network (OPTN) 
(42 CFR Part 121) and, in accordance with Public Law 92-463, was 
chartered on September 1, 2000.

DATES: The agency will receive nominations on a continuous basis.

ADDRESSES: All nominations should be submitted to the Executive 
Secretary, ACOT, Healthcare Systems Bureau, HRSA, Parklawn Building, 
Room 12C-06, 5600 Fishers Lane, Rockville, Maryland 20857. Federal 
Express, Airborne, UPS etc. mail delivery should be addressed to 
Executive Secretary, Advisory Committee on Organ Transplantation, 
Healthcare Systems Bureau, HRSA, at the above address, or via email to: 
PStroup@hrsa.gov and PTongele@hrsa.gov.

FOR FURTHER INFORMATION CONTACT: Patricia A. Stroup, M.B.A., M.P.A., 
Executive Secretary, ACOT, at (301) 443-1127 or email pstroup@hrsa.gov.

SUPPLEMENTARY INFORMATION: As provided by 42 CFR 121.12, the Secretary 
established the ACOT. The ACOT is governed by the Federal Advisory 
Committee Act (5 U.S.C. Appendix 2), which sets forth standards for the 
formation and use of advisory committees.
    The ACOT advises the Secretary on all aspects of organ procurement, 
allocation, and transplantation, and on other such matters that the 
Secretary determines. One of its principal functions is to advise the 
Secretary on federal efforts to maximize the number of deceased donor 
organs made available for transplantation and to support the safety of 
living organ donation.
    The ACOT consists of up to 25 members who are Special Government 
Employees, and 5 ex-officio, non-voting members. Members and the Chair 
shall be appointed by the Secretary from individuals knowledgeable in 
such fields as deceased and living organ donation, health care public 
policy, transplantation medicine and surgery, critical care medicine 
and other medical specialties involved in the identification and 
referral of donors, non-physician transplant professions, nursing, 
epidemiology, immunology, law and bioethics, behavioral sciences, 
economics and statistics, as well as representatives of transplant 
candidates, transplant recipients, living organ donors, and family 
members of deceased and living organ donors. Members shall not serve 
while they are also serving on the OPTN Board of Directors. To the 
extent practicable, Committee members should represent minority, 
gender, and geographic diversity of transplant candidates, transplant 
recipients, organ donors, and family members served by the OPTN. The 
ex-officio, non-voting members shall include the Directors of the 
National Institutes of Health, the Centers for Disease Control and 
Prevention, and the Agency for Healthcare Research and Quality; the 
Administrator of the Centers for Medicare and Medicaid Services; and 
the Commissioner of the Food and Drug Administration--or their 
designees.
    Specifically, HRSA is requesting nominations for voting members of 
the ACOT representing: Health care public policy; transplantation 
medicine and surgery, including pediatric and heart/lung 
transplantation; critical care medicine; nursing; epidemiology and 
applied statistics; immunology; law and bioethics; behavioral sciences; 
economics and econometrics; organ procurement organizations; transplant 
candidates/recipients; transplant/donor family members; and living 
donors. Nominees will be invited to serve up to a 4-year term beginning 
the date of appointment.
    The Department of Health and Human Services (HHS) will consider 
nominations of all qualified individuals with a view to ensuring that 
the ACOT includes the areas of subject matter expertise noted above. 
Individuals may nominate themselves or other individuals, and 
professional associations and organizations may nominate one or more 
qualified persons for membership on the ACOT. Nominations shall state 
that the nominee is willing to serve as a member of the ACOT and 
appears to have no conflict of interest that would preclude the ACOT 
membership. Potential candidates will be asked to provide detailed 
information concerning financial interests, consultancies, research 
grants, and/or contracts that might be affected by recommendations of 
the ACOT to permit evaluation of possible sources of conflicts of 
interest.
    A nomination package should include the following information for 
each nominee: (1) A letter of nomination stating the name, affiliation, 
and contact information for the nominee, the basis for the nomination 
(i.e., what specific attributes, perspectives, and/or skills does the 
individual possess that would benefit the workings of ACOT), and the 
nominee's field(s) of expertise; (2) a biographical sketch of the 
nominee and a copy of his/her curriculum vitae; and (3) the name, 
address, daytime telephone number, and email address at which the 
nominator can be contacted.
    HHS strives to ensure that the membership of HHS Federal advisory 
committees is fairly balanced in terms of points of view represented 
and the committee's function. Every effort is

[[Page 14059]]

made to ensure that the views of women, all ethnic and racial groups, 
and people with disabilities are represented on HHS Federal advisory 
committees. The Department also encourages geographic diversity in the 
composition of the committee. The Department encourages nominations of 
qualified candidates from all groups and locations. Appointment to the 
ACOT shall be made without discrimination on the basis of age, race, 
ethnicity, gender, sexual orientation, disability, and cultural, 
religious, or socioeconomic status.

    Dated: March 6, 2014.
Jackie Pianter,
Deputy Director, Division of Policy and Information Coordination.
[FR Doc. 2014-05375 Filed 3-11-14; 8:45 am]
BILLING CODE 4165-15-P